Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Cash & Current Investments (2021 - 2026)

Core Scientific has reported Cash & Current Investments over the past 6 years, most recently at $1.1 billion for Q1 2026.

  • Quarterly results put Cash & Current Investments at $1.1 billion for Q1 2026, up 52.49% from a year ago — trailing twelve months through Mar 2026 was $1.1 billion (up 52.49% YoY), and the annual figure for FY2025 was $311.4 million, down 62.8%.
  • Cash & Current Investments reached $1.1 billion in Q1 2026 per CORZ's latest filing, up from $311.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $1.1 billion in Q1 2026 and bottomed at $37.6 million in Q3 2022.
  • Median Cash & Current Investments over the past 5 years was $140.4 million (2022), compared with a mean of $311.6 million.
  • The largest annual shift saw Cash & Current Investments skyrocketed 18181.06% in 2022 before it tumbled 81.55% in 2023.
  • Over 5 years, Cash & Current Investments stood at $52.2 million in 2022, then soared by 33.44% to $69.7 million in 2023, then surged by 1100.68% to $837.0 million in 2024, then crashed by 62.8% to $311.4 million in 2025, then soared by 242.15% to $1.1 billion in 2026.
  • Business Quant data shows Cash & Current Investments for CORZ at $1.1 billion in Q1 2026, $311.4 million in Q4 2025, and $453.4 million in Q3 2025.